These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 39152559)

  • 1. Investigations on 5,6,7,8-tetrahydro-[1,2,4]triazolo[1,2-
    Morgenstern O; Giesen U; Garn T; Freitag M; Schmidt K; Großmann A; Trettin A; Thämlitz N; Lemmerhirt C
    Pharmazie; 2024 Aug; 79(7):130-145. PubMed ID: 39152559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and structure elucidation of 2,3,5,6,7,8-hexahydro-1 H-[1,2,4]triazolo[1,2-a]pyridazine-1-thione, 3,3-disubstituted and 2-substituted derivatives and evaluation of their inhibitory activity against inducible nitric oxide synthase.
    Schulz U; Freitag M; Schmidt K; Witetschek M; Polzin M; Morgenstern O
    Pharmazie; 2014 Oct; 69(10):731-44. PubMed ID: 25985562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, chemical behavior, structure elucidation and iNOS inhibitory activity of 1-substituted 3-methylsulfanyl-5,6,7,8-tetrahydro-1
    Schulz U; Grossmann A; Wilde F; Freitag M; Lemmerhirt C; Schulzke C; Link A; Morgenstern O
    Pharmazie; 2017 Jul; 72(7):371-382. PubMed ID: 29441933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigations on synthesis and structure elucidation of novel [1,2,4]triazolo[1,2-a]pyridazine-1-thiones and their inhibitory activity against inducible nitric oxide synthase.
    Schulz U; Grossmann A; Witetschek M; Lemmerhirt C; Polzin M; Haertel B; Wanka H; Morgenstern O
    Bioorg Med Chem; 2013 Sep; 21(17):5518-31. PubMed ID: 23810674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-HAV activity of some newly synthesized triazolo[4,3-b]pyridazines.
    Shamroukh AH; Ali MA
    Arch Pharm (Weinheim); 2008 Apr; 341(4):223-30. PubMed ID: 18214848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, crystallographic studies, and preliminary biological appraisal of new substituted triazolo[4,3-b]pyridazin-8-amine derivatives as tankyrase inhibitors.
    Liscio P; Carotti A; Asciutti S; Karlberg T; Bellocchi D; Llacuna L; Macchiarulo A; Aaronson SA; Schüler H; Pellicciari R; Camaioni E
    J Med Chem; 2014 Mar; 57(6):2807-12. PubMed ID: 24527792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of a New Series of Nitrogen/Sulfur Heterocycles by Linking Four Rings: Indole; 1,2,4-Triazole; Pyridazine; and Quinoxaline.
    Boraei ATA; Sarhan AAM; Yousuf S; Barakat A
    Molecules; 2020 Jan; 25(3):. PubMed ID: 31973234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, antitubercular, antifungal and antibacterial activities of 6-substituted phenyl-2-(3'-substituted phenyl pyridazin-6'-yl)-2,3,4,5-tetrahydropyridazin-3-one.
    Islam M; Siddiqui AA; Rajesh R
    Acta Pol Pharm; 2008; 65(3):353-62. PubMed ID: 18646555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A New Synthesis of Poly Heterocyclic Compounds Containing [1,2,4]triazolo and [1,2,3,4]tetrazolo Moieties and their DFT Study as Expected Anti-cancer Reagents.
    Abdelrehim EM; El-Sayed DS
    Curr Org Synth; 2020; 17(3):211-223. PubMed ID: 32101129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-Phenyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amines as potent and selective inhibitors of glycogen synthase kinase 3 with good cellular efficacy.
    Tavares FX; Boucheron JA; Dickerson SH; Griffin RJ; Preugschat F; Thomson SA; Wang TY; Zhou HQ
    J Med Chem; 2004 Sep; 47(19):4716-30. PubMed ID: 15341487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, structural investigations and biological evaluation of novel hexahydropyridazine-1-carboximidamides, -carbothioamides and -carbothioimidic acid esters as inducible nitric oxide synthase inhibitors.
    Morgenstern O; Wanka H; Röser I; Steveling A; Kuttler B
    Bioorg Med Chem; 2004 Mar; 12(5):1071-89. PubMed ID: 14980620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bicyclic [b]-heteroannelated pyridazine derivatives. Part 6. Aromatization of some tetrahydrotriazolo[4,3-b]pyridazine derivatives with potential activity as benzodiazepine receptor ligands.
    Lange J; Karolak-Wojciechowska J; Gniewosz M; Kuliński T; Plenkiewicz J
    Acta Pol Pharm; 1997; 54(4):299-305. PubMed ID: 9511458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preparation of N,N'-diguanyl-tetrahydro and hexahydropyridazine and of tetra and hexahydro-pyridazino-dihydrotriazolic derivatives of pharmacological interest].
    Pirisino G; Sparatore F
    Boll Chim Farm; 1974 Aug; 113(8):421-7. PubMed ID: 4447667
    [No Abstract]   [Full Text] [Related]  

  • 14. Novel chalcone/aryl carboximidamide hybrids as potent anti-inflammatory via inhibition of prostaglandin E2 and inducible NO synthase activities: design, synthesis, molecular docking studies and ADMET prediction.
    Ibrahim TS; Moustafa AH; Almalki AJ; Allam RM; Althagafi A; Md S; Mohamed MFA
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1067-1078. PubMed ID: 34027787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and discovery of triazolo-pyridazine-6-yl-substituted piperazines as effective anti-diabetic drugs; evaluated over dipeptidyl peptidase-4 inhibition mechanism and insulinotropic activities.
    Bindu B; Vijayalakshmi S; Manikandan A
    Eur J Med Chem; 2020 Feb; 187():111912. PubMed ID: 31812034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-based design of 3-aryl-6-amino-triazolo[4,3-b]pyridazine inhibitors of Pim-1 kinase.
    Grey R; Pierce AC; Bemis GW; Jacobs MD; Moody CS; Jajoo R; Mohal N; Green J
    Bioorg Med Chem Lett; 2009 Jun; 19(11):3019-22. PubMed ID: 19414255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of novel triazolo[4,3-b]pyridazin-3-yl-quinoline derivatives as PIM inhibitors.
    Martínez-González S; Rodríguez-Arístegui S; Gómez de la Oliva CA; Hernández AI; González Cantalapiedra E; Varela C; García AB; Rabal O; Oyarzabal J; Bischoff JR; Klett J; Albarrán MI; Cebriá A; Ajenjo N; García-Serelde B; Gómez-Casero E; Cuadrado-Urbano M; Cebrián D; Blanco-Aparicio C; Pastor J
    Eur J Med Chem; 2019 Apr; 168():87-109. PubMed ID: 30802730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploration and optimization of substituted triazolothiadiazines and triazolopyridazines as PDE4 inhibitors.
    Skoumbourdis AP; Leclair CA; Stefan E; Turjanski AG; Maguire W; Titus SA; Huang R; Auld DS; Inglese J; Austin CP; Michnick SW; Xia M; Thomas CJ
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3686-92. PubMed ID: 19464886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The synthesis and structure-activity relationship of pyridazinones as glucan synthase inhibitors.
    Ting PC; Kuang R; Wu H; Aslanian RG; Cao J; Kim DW; Lee JF; Schwerdt J; Zhou G; Wainhaus S; Black TA; Cacciapuoti A; McNicholas PM; Xu Y; Walker SS
    Bioorg Med Chem Lett; 2011 Mar; 21(6):1819-22. PubMed ID: 21316223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and anticonvulsant activity of a new 6-alkoxy-[1,2,4]triazolo[4,3-b]pyridazine.
    Guan LP; Sui X; Deng XQ; Quan YC; Quan ZS
    Eur J Med Chem; 2010 May; 45(5):1746-52. PubMed ID: 20116141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.